(Circulation. 1997;96:1776-1782.)
© 1997 American Heart Association, Inc.
Articles |
Assessment of Coronary Reperfusion After Thrombolysis With a Model Combining Myoglobin, Creatine Kinase–MB, and Clinical Variables
From the Department of Pathology (R.H.C., S.-H.D., G.L.A.), University of Maryland School of Medicine, Baltimore; Department of Medicine (E.M.O., S.P., L.K.N., R.M.C.), Division of Cardiology, Duke University Medical Center, Durham, NC; Department of Cardiology (E.J.T.), Cleveland Clinic Foundation, Cleveland, Ohio; The Christ Hospital (D.J.K.), Cincinnati, Ohio; Lancaster (Pa) General Hospital (S.J.W.); and Moses Cone Hospital (T.C.W.), Greensboro, NC.
Correspondence to Dr Robert H. Christenson, Clinical Pathology, University of Maryland Medical Center, 22 S Greene St, Baltimore, MD 21201.
Background Several biochemical markers have been investigated for the noninvasive assessment of reperfusion after myocardial infarction. Because myoglobin is released very soon after myocardial injury and clears rapidly after reperfusion, it may prove to be an excellent marker of occlusion and reperfusion.
Methods and Results We examined the relation between various myoglobin measures and Thrombolysis In Myocardial Infarction (TIMI) flow grade in 96 patients enrolled in a study of front-loaded thrombolysis who underwent 90-minute angiography. We also combined myoglobin measures with models that include clinical and creatine kinase–MB variables. The myoglobin level measured within 10 minutes of acute angiography showed the best overall performance and was used for later analyses. Of the clinical variables examined, only time from symptom onset to thrombolysis and chest pain grade at angiography discriminated among TIMI flow grades. Combining the 90-minute myoglobin level and these clinical variables showed a significant difference (P<.0001) between both TIMI 3 versus TIMI 0 through 2 and TIMI 2 or 3 versus TIMI 0 or 1 flow. When the 90-minute myoglobin level was added to an established predictive model containing clinical variables and creatine kinase–MB measures, its contribution remained significant (P=.044). The area under the receiver operator characteristic curve for this combined model was .88.
Conclusions A single myoglobin measurement obtained 90 minutes after the start of thrombolysis, combined with select clinical variables and creatine kinase–MB levels, enhances the noninvasive prediction of reperfusion after myocardial infarction.
Key Words: creatine kinase • myoglobin • reperfusion • thrombolysis
This article has been cited by other articles:
 |
|
 |
|
  NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, and R. H. Christenson National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Circulation, April 3, 2007; 115(13): e356 - e375. [Full Text] [PDF]
|
|
|
|
 |
|
 NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Clin. Chem., April 1, 2007; 53(4): 552 - 574. [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Gershlick, A. Stephens-Lloyd, S. Hughes, K. R. Abrams, S. E. Stevens, N. G. Uren, A. de Belder, J. Davis, M. Pitt, A. Banning, et al. Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction N. Engl. J. Med., December 29, 2005; 353(26): 2758 - 2768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Karavidas, A. D. Vrachatis, M. A. Alpert, D. J. Nikas, D. J. Achtypis, M. G. Foukarakis, E. P. Matsakus, C. S. Thedocharis, and A. A. Zacharoulis Primary Stenting Produces Earlier and More Efficient Myocardial Reperfusion than Primary PTCA Alone in Patients with Acute ST Segment Elevation MI Angiology, March 1, 2003; 54(2): 195 - 203. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Iraculis, A. Cequier, J. A. Gomez-Hospital, M. Sabate, J. Mauri, E. Fernandez-Nofrerias, B. Garcia del Blanco, F. Jara, and E. Esplugas Early dysfunction and long-term improvement in endothelium-dependent vasodilation in the infarct-related artery after thrombolysis J. Am. Coll. Cardiol., July 17, 2002; 40(2): 257 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Christenson, S. H. Duh, W. R. Sanhai, A. H.B. Wu, V. Holtman, P. Painter, E. Branham, F. S. Apple, M. Murakami, and D. L. Morris Characteristics of an Albumin Cobalt Binding Test for Assessment of Acute Coronary Syndrome Patients: A Multicenter Study Clin. Chem., March 1, 2001; 47(3): 464 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M J M de Groot, A M M Muijtjens, M L Simoons, W T Hermens, and J F C Glatz Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma Heart, March 1, 2001; 85(3): 278 - 285. [Abstract] [Full Text]
|
|
|
|
|
|
M. T. Roe, E. M. Ohman, A. C. P. Maas, R. H. Christenson, K. W. Mahaffey, C. B. Granger, R. A. Harrington, R. M. Califf, and M. W. Krucoff Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion J. Am. Coll. Cardiol., January 1, 2001; 37(1): 9 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H.B. Wu, F. S. Apple, W. B. Gibler, R. L. Jesse, M. M. Warshaw, and R. Valdes Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases Clin. Chem., July 1, 1999; 45(7): 1104 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Christenson and H. M. E. Azzazy Biochemical markers of the acute coronary syndromes Clin. Chem., August 1, 1998; 44(8): 1855 - 1864. [Abstract] [Full Text] [PDF]
|
|